Benzinga
Benzinga
Benzinga
lunedì, settembre 21

CME Group Inc

CMENASDAQ
Trade with Public
Trade with Public
$274.68
-1.33-0.48%
Ult. Agg.: Sep 21, 2:55 PM
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoDividendiConfrontaOpzioniRapporto azionario

CME Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for CME Group (CME).

Price Target Range — 9 Quarters

Analyst Consensus — 17 Analysts

8Buy
6Hold
3Sell
Consensus RatingOutperform# Analysts17Avg. Consensus PT$279Upside to Avg. PT+1.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Sep 3, 2026TD CowenBill KatzMaintainedBuy$292
Aug 19, 2026Deutsche BankBrian BedellDowngradeBuy→Hold$286→$270
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Reiterates Buy on CME Group, Maintains $292 Price Target

TD Cowen analyst Bill Katz reiterates CME Group (NASDAQ:CME) with a Buy and maintains $292 price target.
Benzinga Newsdesk

PRO
Deutsche Bank Downgrades CME Group to Hold, Lowers Price Target to $270

Deutsche Bank analyst Brian Bedell downgrades CME Group (NASDAQ:CME) from Buy to Hold and lowers the price target from $286 to $270.
Benzinga Newsdesk

PRO
B of A Securities Maintains Underperform on CME Group, Raises Price Target to $230

B of A Securities analyst Craig Siegenthaler maintains CME Group (NASDAQ:CME) with a Underperform and raises the price target from $226 to $230.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $330

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $324 to $330.
Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on CME Group, Lowers Price Target to $295

Piper Sandler analyst Patrick Moley maintains CME Group (NASDAQ:CME) with a Overweight and lowers the price target from $329 to $295.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on CME Group, Lowers Price Target to $324

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and lowers the price target from $353 to $324.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved